维普中文期刊产品整合服务
36篇 您的检索式:作者名="CHRISTOULAS D"
    题名 作者 年代 出处 被引量
1Dickkopf-1:a suitable target for the management of myeloma bone disease显示文摘GAVRIATOPOULOU M DIMOPOULOS M A CHRISTOULAS D 2009Expert Opin Ther Target2009,13,7:1
2DiffuseMRI marrow pattern correlates with increased angiogenesis,ad-vanced disease features and poor prognosis in newly diagnosedmyeloma treated with novel agents显示文摘Moulopoulos LA Dimopoulos MA Christoulas D 2010Leukemia2010,24,6:1
3Prediction of leachate quality from sanitary landfills显示文摘Katsiri A K Bosdogianni A Christoulas D 1999J Environ Eng ASCE1999,125,10:1
4Dickkopf-l:a suitable target for the management of mye- loma bone disease显示文摘Gavriatopoulou M Dimopoulos MA Christoulas D 2009Expert Opin Ther Targets2009,13,7:1
5Prediction of le aehable quality from sanitary landfills显示文摘Kouzeli-Katsiri A Bosdogianni A Christoulas D 1999Journal of Environ Eng1999,125,10:1
6Dickkopf-l: a suitable target for the management of myeloma bone disease显示文摘Gavriatopoulou M Dimopoulos MA Christoulas D 2009Expert Opin Ther Targets2009,13,7:1
7High circulat-ing sclerostin is present in patients with thalassemia-asso- ciated osteoporosis and correlates with bone mineral den- sity显示文摘Voskaridou E Christoulas D Plata E 2012Horm Metab Res2012,44,12:1
8Dickkopf- 1 :a suitable target for the management of myelo- ma bone disease 显示文摘Gavriatopoulou M Dimopoulos MA Christoulas D 2009Expert Opin Ther Targets2009,13,7:1
9Elevated cir- culating sclerostin correlates with advanced disease fea- tures and abnormal bone remodeling in symptomatic mye- loma: reduction post-bortezomib monotherapy显示文摘Terpos E Christoulas D Katodritou E 2012Int J Cancer2012,131,6:1
10Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma显示文摘Terpos E Kanellias N Christoulas D 2013Onco Targets Ther2013,106,:1
11Contipuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis:long-term follow-up of a randomized,place,bo-controlled trial显示文摘Voskaridou E Christoulas D Konstantinidou M 2008Haematologica JT2008,93,10:1
12Dickkopf-1: a suitable target for the management of myeloma bone disease显示文摘Gavriatopoulou M Dimopoulos M A Christoulas D 2009Expert Opin Ther Targets2009,13,7:1
13High circulating sclerostin is present in patients with thalassemia- associated osteoporosis and correlates with bone mineral density 显示文摘Voskaridou E Christoulas D Plata E 2012Horm Metab Res2012,44,12:1
14Dickkopf-1:a suitable target for the management of myeloma bone disease显示文摘Gavriatopoulou M Dimopoulos M A Christoula D 2009Expert Opin Ther Targets2009,13,7:1
15The chronic kidney disease epidemlology collaboration eystatin C(CKD-EPI-CysC)e- quation has an Independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma:is it time to change from MDRD to CKD-EPI-CysC equations显示文摘Terpos E Christoulas D Kastritis E 2013Eur J Haematol2013,91,4:1
16Rankl inhibition: clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases 显示文摘Terpos E Efstathiou E Christoulas D 2009Expert Opin Biol Ther2009,9,4:1
17Pomalidomide: A novel drug to treat relapsed and refractory multiple myeloma显示文摘Terpos E Kaneltias N Christoulas D 2013Onco Targets 'Iher2013,6,1:1
18Ultraviolet disinfection of secondary and tertiary effluent in the Mediterranean region 显示文摘Andreadakis A Mamais D Christoulas D 1999Water Science and Technology1999,40,45:1
19Ultraviolet disinfection of secondary and teritiary effulent in the Mediterranean region显示文摘Andreadakis A Mamais D Christoulas D and Kabylafka S 1999Wat Sci Tech1999,40,45:1
20Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy显示文摘Terpos E Kastritis E Christoulas D 2012Ann Oncol2012,23,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费